Relief for Babies with Cystic Fybrosis

Sunday, July 21st, 2019

Parents of babies with cystic fibrosis will soon have cheaper access to a life-saving drug.

From next month, Kalydeco will be subsidised on the Pharmaceutical Benefits Scheme.

The change is expected to save families up to $300,000 a year.

Federal Health Minister Greg Hunt says it’s life-changing.

“What Kalydeco can do is it can improve the capacity of these young children to breathe,” he says. “It gives them a better quality of life, it gives them a longer life, and ultimately it gives them access to further medicines that will help let them them live a rich, full life.”

Early intervention with the drug raises the life expectancy for cystic fibrosis sufferers.


The Word for Today



Donate to vision

Over 80% of our income is from the freewill gifts of wonderful people just like you.
So thank you for helping. Your generous support is 'Connecting Faith to Life'.